Mural Oncology PLC — Director's Dealing 2024

Jun 5, 2024

SEC Form 4/A — Form 4/A

Issuer: Mural Oncology plc (MURA)
CIK: 0001971543
Period of Report: 2024-05-30

Reporting Person: Cuss Francis M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-30	Stock Option (right to buy)	$3.35	A	8462	Acquired	2034-05-29	Ordinary Shares (8462)	Direct

Footnotes

F1: This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer.

F2: This amendment to Form 4 is being filed solely to correct the price of the derivative security, which was previously reported as being $3.35 due to a scrivener's error.